GPAT financial statements and SEC filings
GPAT annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | – | -$551.92K | $11.89M | 10-K |
| 2024-12-31 | – | -$564.97K | $8.67M | 10-K |
| 2023-12-31 | – | -$14.04K | -$14.04K | 10-K |
GPAT annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $309.37M | $14.67M | -$14.48M | 10-Q |
| 2024-12-31 | $297.47M | $14.67M | -$13.93M | 10-K |
| 2023-12-31 | $530.24K | $628.18K | -$97.94K | 10-K |
GPAT annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | -$372.23K | – | $1.31K | 10-K |
| 2024-12-31 | -$584.72K | – | $288.57M | 10-K |
| 2023-12-31 | -$10.97K | – | $10.42K | 10-K |